Yi Li - HOB Biotech Financial Manager
| 688656 Stock | 89.05 5.10 6.08% |
Executive
Yi Li is Financial Manager of HOB Biotech Group
| Age | 48 |
| Address | Building C6 and C10, Suzhou, China, 215123 |
| Phone | 86 512 6956 1996 |
| Web | https://www.hobiotech.com |
HOB Biotech Management Efficiency
The company has return on total asset (ROA) of 0.0266 % which means that it generated a profit of $0.0266 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0439 %, meaning that it generated $0.0439 on every $100 dollars invested by stockholders. HOB Biotech's management efficiency ratios could be used to measure how well HOB Biotech manages its routine affairs as well as how well it operates its assets and liabilities. At present, HOB Biotech's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 749.9 M, whereas Non Currrent Assets Other are forecasted to decline to about 16.5 M.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Tang Yun | Jinhui Liquor Co | 51 | |
| Lianfeng Cao | Shandong Sinoglory Health | 54 | |
| Naiyu Li | Shandong Sinoglory Health | 45 | |
| Yuqiu Lin | Fuzhou Rockchip Electronics | 48 | |
| Liangping Cai | By health | 51 | |
| Chengxiao Peng | Dongguan Tarry Electronics | 47 | |
| Hong Chen | By health | 59 | |
| Jun Feng | Aier Eye Hospital | 46 | |
| Zhenhong Zhang | Dongguan Tarry Electronics | 50 | |
| Xuan Wu | Dongguan Tarry Electronics | 43 | |
| Bin Zhang | Jinhui Liquor Co | 42 | |
| Aiming Li | Aier Eye Hospital | 55 | |
| Li Wang | Aier Eye Hospital | 51 | |
| Jijun Li | Shandong Sinoglory Health | 50 | |
| Haimin Wang | Fuzhou Rockchip Electronics | 58 | |
| Zhiguo An | Shandong Sinoglory Health | 49 | |
| Zhao Zhang | Shandong Sinoglory Health | 47 | |
| Shi Wu | Aier Eye Hospital | 53 | |
| Yan Zhang | Aier Eye Hospital | 55 | |
| Dechao Ren | Weihai Honglin Electronic | 39 | |
| Qiang Fang | Fuzhou Rockchip Electronics | 58 | |
Management Performance
| Return On Equity | 0.0439 | ||||
| Return On Asset | 0.0266 |
HOB Biotech Group Leadership Team
Elected by the shareholders, the HOB Biotech's board of directors comprises two types of representatives: HOB Biotech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of HOB. The board's role is to monitor HOB Biotech's management team and ensure that shareholders' interests are well served. HOB Biotech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, HOB Biotech's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Xiaohua Huang, Deputy Manager | ||
| John Li, Chairman GM | ||
| Ruoliang Sun, Deputy Manager | ||
| Qingxin Liu, Director GM | ||
| Shuyan Han, Chief Officer | ||
| Aixiang Xie, Secretary | ||
| Yi Li, Financial Manager | ||
| Kai Wang, Board GM | ||
| Jerry Li, Chief Officer |
HOB Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is HOB Biotech a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0439 | ||||
| Return On Asset | 0.0266 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 5.62 B | ||||
| Shares Outstanding | 63.06 M | ||||
| Shares Owned By Insiders | 77.33 % | ||||
| Shares Owned By Institutions | 3.10 % | ||||
| Price To Book | 6.97 X | ||||
| Price To Sales | 13.99 X |
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Other Information on Investing in HOB Stock
HOB Biotech financial ratios help investors to determine whether HOB Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HOB with respect to the benefits of owning HOB Biotech security.